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Abstract.  A large body of evidence indicates that mi- 
crotubules (MTs) conduct organelle transport in axons, 
but recent studies on extruded squid axoplasm have 
suggested that actin microfilaments (MFs) may also 
play a role in this process. To investigate the separate 
contributions to transport of each class of cytoskeletal 
element in intact vertebrate axons, we have monitored 
mitochondrial movements in chick sympathetic neu- 
rons experimentally manipulated to eliminate MTs, 
MFs, or both. First, we grew neurons in the continuous 
presence of: (a) cytochalasin E to create neurites which 
had never contained MFs; or (b) nocodazole or vinblas- 
tine to produce neurites which had never contained 
MTs. Mitochondria moved bidirecfionally at normal 
velocities along the length of neurites which contained 
MTs and lacked MFs, but did not even enter neurites 
grown without MTs but containing MFs. In a second 
approach, we treated established neuronal cultures 
with cytoskeletal drugs to disrupt either MTs or MFs in 
axons already containing mitochondria. In cytochala- 
sin-treated cells, which retained MTs but lacked MFs, 
average mitochondrial velocity increased in both direc- 
tions, but net directional transport decreased. In vin- 
blastine-treated cells, which lacked MTs but retained 
essentially normal levels of MFs, mitochondria contin- 
ued to move bidirectionally but the average mitochon- 
drial velocity and excursion length were reduced for 
both directions of movement, and the mitochondria 
spent threefold as much time moving in the retrograde 
as in the anterograde direction, resulting in net retro- 
grade transport. Treatment of established cultures with 
both drugs produced neurites lacking MTs and MFs but 
still rich in neurofilaments; these showed a striking ab- 
sence of any mitochondrial motility. These data indi- 
cate that axonal organelle transport can occur along 
both MTs and MFs in vivo, but with different velocities 
and net transport properties. 
RGANELLE transport in animal cells is widely con- 
sidered to be  an exclusively microtubule-depen- 
dent process. Evidence from various cell types in- 
dicates  that  microtubule  (MT)m-dependent movement  is 
essential to transport and position in several classes of or- 
ganelles, including the Golgi apparatus (Corth6sy-Theulaz 
et al., 1992; Ho et al., 1989), endoplasmic reticulum (Terasaki 
et al., 1984, 1986), and lysosomes (Hollenbeck and Swan- 
son,  1990). Axonal organelle transport in particular has 
been thought to be entirely MT-dependent. This view de- 
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veloped from a large body of morphological and pharma- 
cological  studies  (reviewed  by  Grafstein  and  Forman, 
1980), and was reinforced by the images of axoplasm  ob- 
tained  by  freeze-etch  electron  microscopy  (Hirokawa, 
1982; Hirokawa and Yorifuji, 1986), by the observations of 
reactivated axoplasmic  organelle transport  using  video- 
enhanced microscopy  (Allen  et  al.,  1985; Brady et  al., 
1985; Schnapp et al., 1985), and by the subsequent discov- 
ery and characterization of the MT-based motors kinesin 
(Brady, 1985; Vale et al., 1985; Scholey et al., 1985) and cy- 
toplasmic dynein (Vallee et al., 1988; Shpetner et al., 1988; 
Schnapp and Reese, 1989; Schroer et al., 1989). 
However, there has also existed in parallel a more dif- 
fuse body of studies  indicating  a role for actin microfila- 
ment  (MF)-based  motility in  organelle  transport.  First, 
other eukaryotic cells, such as the giant alga Nitella, have 
well-developed  systems  of  actomyosin-based  organelle 
transport; indeed, this was among the first powerful sys- 
tems established for the in vitro study of organelle motility 
(Sheetz  and  Spudich,  1983). Second,  axonal  organelle 
transport has been shown to continue after MT disruption 
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tially inhibited by the introduction of agents that specifi- 
cally disrupt MFs (Goldberg, 1982; Goldberg et al.,  1980; 
Brady et al.,  1984).  Finally, since the general demonstra- 
tions that neuronal tissue was rich in actin (Fine and Bray, 
1971) and myosin (Burridge and Bray, 1975), several myo- 
sin isotypes have also been detected there, including myo- 
sins I (Li and Chantler, 1992), II (Sun and Chantler, 1991, 
1992; Mochida et al., 1994; Li et al., 1994), V  (Espreafico 
et al.,  1992;  Cheney et al.,  1993a),  and VI  (Hasson  and 
Mooseker, 1994), and it has been suggested that these may 
be involved in  neuronal organelle transport  (Mooseker, 
1993). 
Thus, it should not seem entirely heretical that recent 
re-examinations of the role of MF-based transport in axo- 
plasm have suggested that MFs and their associated motor 
proteins might also support axonal organelle movement. 
Since  Kuznetsov  and  co-workers  (1992)  first  observed 
MT-independent organelle movements in  extruded axo- 
plasm  that were strongly indicative of actomyosin-based 
motility, it has been demonstrated that isolated axoplas- 
mic  organelles  have  myosin  on  their  surfaces,  and  can 
move toward the barbed end of MFs in vitro (Bearer et al., 
1993; Kuznetsov et al.,  1994; Langford et al., 1994).  How- 
ever, the role of MF-based transport and its significance 
relative to MT-based transport in intact axons remain un- 
clear. 
In this study, we sought to address these questions di- 
rectly by quantitative analysis of organelle movement in 
cultured neurons. We specifically followed the movement 
of mitochondria, since they can be unambiguously identi- 
fied in live neurons by staining with lipophilic cationic dyes 
(Johnson et al., 1981; Magrassi et al., 1987), they exhibit a 
broad range of motile behaviors and velocities within ax- 
ons (Martz et al.,  1984; Forman et al.,  1987; Morris and 
Hollenbeck, 1993), and their motility is profoundly regu- 
lated by the physiological state of the neuron (Morris and 
Hollenbeck, 1993). In addition, some evidence has already 
suggested that mitochondria can enter regions of the cell 
which  lack  MTs  but  contain  MFs  (Bradley  and  Satir, 
1979). To investigate the contributions of the different cy- 
toskeletal filament systems to the transport of mitochon- 
dria within living vertebrate axons, we adapted techniques 
originated by Heidemann and colleagues (1990) to grow 
neurites in the absence of MTs, and by Marsh and Letour- 
neau (1984) to grow neurites which lack MFs. We report 
that  mitochondria  are  transported  along  both MTs  and 
MFs in living cells, but that the motile behaviors of mito- 
chondria are dramatically different on the two cytoskeletal 
tracks. 
Materials and Methods 
Materials 
Unless otherwise  specified,  all  materials  and  reagents  were  obtained 
from Sigma Chemical Co.  (St.  Louis, MO). Rhodamine 123  (R123)  and 
rhodamine-conjugated phalloidin (R-phal) were obtained from Molecular 
Probes, Inc. (Eugene, OR). Extracell coverslips were obtained from Ac- 
curate Chemical and Scientific Corp. (Westbury, NY). DM1A anti-tubulin 
was  obtained  from  Boehringer-Mannheim Biochemicals  (Indianapolis, 
IN). Texas red, horse radish peroxidase-, and alkaline  phosphatase-con- 
jugated secondary antibodies were obtained from Vector Labs (Burlin- 
game, CA). 
Neuronal Cell Culture and Drug Treatments 
Sympathetic chain ganglia  were dissected from 9-11  d chicken embryos, 
dissociated,  and grown on coverslips as previously described (Hollenbeck 
and  Bray,  1987).  Cells  were grown in  Liebovitz  L-15  medium supple- 
mented with 10%  fetal bovine serum, 0.6%  glucose,  2 mM L-glutamine, 
100 IU/ml penicillin,  100 p.g/ml streptomycin, 50 ng/ml nerve growth fac- 
tor,  and  0.5%  methylcellulose.  Coverslips were  treated  with  1  mg/ml 
polylysine overnight at 4°C, then with 10 ixg/ml laminin in Hanks balanced 
salt solution for 0.5-2 h before use. To grow neurites lacking  MFs from 
sympathetic neurons, we modified the technique of Marsh and Letour- 
neau (1984) and grew cells for 3 d in the continuous presence of 20 p~g/ml 
cytochalasin  E  diluted  into  growth medium from  a  4  mg/ml  stock  in 
DMSO.  To grow neurites lacking  MTs, we modified the  technique  of 
Lamoreaux et al. (1990)  and cultured cells on polylysine/laminin-treated 
coverslips for 1 d in the continuous presence of 100-200 nM vinblastine di- 
luted into culture medium from a 4 mM stock in methanol. Alternatively, 
cells could be grown on Extracell coverslips for 1 d in the continuous pres- 
ence of 0.4 Ixg/ml nocodazole diluted from a stock of 0.2 mg/ml in DMSO. 
To depolymerize the MFs in established cultures (grown in normal me- 
dium for 1 d before experimental treatment), we treated them with 20/~g/ 
ml cytochalasin for 30 rain, and then either transferred them to the micro- 
scope for low light level video microscopy or fixed them for immunofluo- 
rescent staining.  To  depolymerize  the  MTs in established cultures, we 
treated them with 1 ~M vinblastine in culture medium without methylcel- 
lulose for 60 min before fixing or transferring live to the microscope. To 
depolymerize both MFs and MTs in established cultures, we incubated the 
cultures in vinblastine-containing medium for 30 min, and then in vinblas- 
tine plus cytochalasin-containing medium for an additional 30 min prior to 
either fixation or transferring live to the microscope. Control cells were 
treated  simultaneously with the same doses of methanol as vinblastine- 
treated cells (0.025 %) and/or with the same dose of DMSO as cytochala- 
sin-treated cultures (0.5 %). 
Preparation for Immunofluorescence Microscopy and 
Electron Microscopy 
For light microscope fluorescent staining of MTs, NFs, or MFs, cells were 
simultaneously fixed  and permeabilized in 2%  formaldehyde, 0.1%  glu- 
taraldehyde, 0.12 M sucrose, 0.5%  Triton X-100, 2 mM EGTA, in HBSS, 
pH 7, at 37°C for 15 min, and then changed to the same solution without 
Triton for 8-10 min. Cells were blocked in 3% BSA in PBS for 15 min at 
25°C or overnight at 4°C, and then incubated for 1 h in primary antibody: 
either monoclonal antibody DM1A  to label  MTs (Breitling  and  Little, 
1986)  and/or polyclonal  antibody  NF70  to  label  neurofilaments (NFs) 
(Hollenbeck and Bray, 1987). For double-labeling of MTs and NFs, pri- 
mary antibodies were applied simultaneously, and secondary antibodies in 
sequence. Secondary antibodies were FITC-conjugated horse anti-mouse 
IgG,  FITC-conjugated  goat  anti-rabbit  IgG,  or  Texas  red-conjugated 
donkey anti-rabbit IgG, all at 1 p.g/ml. MFs were labeled after secondary 
antibody treatment by incubation for 1 h in 0.1mg/ml  R-phal. Coverslips 
were mounted in 1 mg/ml p-phenylenediamine in 90% glycerol,  10%  10x 
PBS (Johnson and Araujo, 1981) and observed using a Zeiss IM35 micro- 
scope with a 63x  Planapochromatic objective.  Control and drug-treated 
cells  were fixed,  processed, embedded,  and  sectioned  for transmission 
electron microscopy as previously described (Hollenbeck, 1993). 
Measurements of Mitochondrial  Motility 
To view mitochondria in living, drug-treated cells, we added 0.5-1  p.g/ml 
R123 to the drug-containing medium 30 min before the end of drug treat- 
ment, and then rinsed the cells with drug-containing medium without dye. 
Cultures were placed on a Zeiss IM35 microscope with a 37°C air curtain 
stage warmer and R123-1abeled  mitochondria were viewed by epifluores- 
cence  illumination with a  tungsten light  source.  Images were captured 
with a  Hamamatsu intensified CCD camera and recorded with a  Pana- 
sonic AG-7300 sVHS video recorder after frame averaging with an Image-1 
Image Analysis System (Universal Imaging Corp., West Chester,  PA). 
Due to the high density of mitochondria in control cells, these axons were 
viewed by video-enhanced  phase contrast microscopy,  using a Hamamatsu 
Newvicon camera and an Image-1 image analysis  system to provide back- 
ground  subtraction  and  contrast enhancement.  (Phase-dark  organelles 
which were 0.5-tzm across and at least 1-~Lm long were known to be mito- 
chondria based on extensive direct comparisons between phase contrast 
and  R123  epifluorescence images.) Movements of individual  mitochon- 
dria  were quantified  from video  tape  recordings with a  Mark-V  video 
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Measure software (gift of Steven M. Block,  Princeton University, Prince- 
ton, NJ) as previously described (Morris and Hollenbeck, 1993). In vin- 
blastine-treated cultures, to ensure that we were observing true mitochon- 
drial motility rather than the results of possible axonal retraction or bulk 
axoplasmic flow, we applied three selection criteria:  (a) Only axons that 
did  not move relative  to the substratum during the observation period 
were considered.  (b) Only axons showing bidirectional  and/or saltatory 
mitochondrial movement were considered; those showing slow, simulta- 
neous, and unidirectional movement of all mitochondria were rejected.  (c) 
Only mitochondrial movements within sections of the axon which were 
thin, of uniform caliber,  and lacking varicosities were considered. To pre- 
vent bias in selection of moving vs. stationary mitochondria for measure- 
ment, all visible mitochondria which met the above criteria were tracked 
for the  entire time that they remained in focus.  All mitochondrial dis- 
placement  data  for one  drug  condition  were then pooled.  In cultures 
treated simultaneously with vinblastine and cytochalasin, we ensured de- 
tection of any mitochondrial movements that might take place by moni- 
toring all mitochondria visible  in a viewing field which met only criterion 
(a) above for the entire time they remained in focus. 
Results 
Mitochondrial  Distribution  in Neurites Grown in the 
Absence of F-Actin or Absence of MTs 
To determine if MFs or MTs were necessary or sufficient 
for the  transport  of mitochondria in  neuronal processes, 
we began by adapting previously published techniques for 
growing neurites which lack MFs but contain MTs (Marsh 
and Letourneau, 1984), or which lack MTs but contain MFs 
(Lamoureux et  al.,  1990).  Although  the  effects of these 
procedures  on the  MTs  and  MFs  have been extensively 
characterized, we examined our cultures using anti-tubulin 
immunofluorescence,  anti-neurofilament  immunofluores- 
cence, or R-phal staining to detect MTs, NFs, and MFs, re- 
spectively.  Sympathetic  neurons  grown  on  an  adhesive 
substratum for 3-4 d  in the continuous presence of cyto- 
chalasin E  (Marsh and Letourneau,  1984)  extended neu- 
rites  which  completely lacked  MFs  but  contained  MTs 
along their entire lengths (Fig. 1). NFs in these cells were 
disrupted  as well, appearing sparse and fragmented com- 
pared to control cells where they are extensive and contin- 
uous throughout all processes (data not shown). Neurons 
grown for i  d on adhesive substrata in the continuous pres- 
ence  of either vinblastine  or nocodazole  (Lamoureux et 
al.,  1990)  extended  neurites  which  appeared  completely 
devoid  of  MTs  but  contained  MFs  along  their  entire 
lengths as shown in Fig. 1. NFs in vinblastine-treated cells 
were also disrupted,  being either entirely absent or con- 
fined to the cell body where they colocalized with the few 
MTs present in these cells. The distribution of mitochon- 
dria in the cytochalasin-treated vs. vinblastine-treated pro- 
cesses  was  strikingly  different.  Mitochondria,  detected 
with R123 (Johnson et al., 1981), were distributed through- 
out MT-containing neurites grown in cytochalasin (Fig. 2) 
where  they  moved  bidirectionally,  often  at  rates  faster 
than 1 txm/s. In contrast, in neurons grown in vinblastine, 
mitochondria were entirely confined to the cell bodies and 
did  not  even  enter  into  the  MF-containing  neurites  of 
these cells (Fig. 2). 
Mitochondrial  Behavior in Established Neuronal 
Cultures after MF and~or MT Depolymerization 
The inability of mitochondria to move from the cell body 
into neurites that lacked MTs suggested that at least antero- 
grade mitochondrial transport could not occur along MFs 
alone. In order to investigate whether mitochondria were 
capable of retrograde transport along MFs, we first grew 
neurons under normal conditions for 1 d, allowing them to 
produce long axons that contained MTs, MFs (Fig. 3), and 
NFs (Fig. 5) and exhibited abundant mitochondrial trans- 
port (Morris and Hollenbeck, 1993).  We then treated the 
cultures with either cytochalasin E  to disrupt MFs or vin- 
blastine  to  depolymerize MTs,  or  both  drugs  to  disrupt 
MFs and MTs simultaneously. As shown by R-phal stain- 
ing,  a  30-min exposure  to 20  ixg/ml  cytochalasin E  pro- 
foundly disrupted  the  normal  actin  cytoskeleton leaving 
only a few small and scattered loci of staining in the axons 
and  cell  bodies,  while  the  MT  staining  remained  unaf- 
fected (Fig. 3).  Conversely, treating established neuronal 
cultures with 1 ~M vinblastine for 60 min virtually elimi- 
nated MT immunofluorescent staining while the MFs re- 
mained intact (Fig. 3).  Although a high vinblastine level 
was necessary in order to depolymerize the stabilized MTs 
in established cultures,  the MTs disappeared in a  consis- 
tent time-dependent pattern starting in the region of the 
growth cone and progressing back toward  the  cell body. 
After 60 min of vinblastine exposure, 82% of 11,410 Ixm of 
axon screened was devoid of anti-tubulin staining, and the 
remaining  18%  where  residual  anti-tubulin  staining  was 
present was adjacent to the cell bodies within slightly thicker 
segments of axon. Whether MFs or MTs were disrupted 
individually, or both arrays were completely disrupted by 
simultaneous treatment with 20 Ixg/ml cytochalasin and 1 
I~M vinblastine, the NF array looked indistinguishable from 
control  cells  when  assayed  by  indirect  immunofluores- 
cence (Fig. 5). We confirmed the absence of MTs in vin- 
blastine-treated axons by thin section electron microscopy. 
While control axons displayed many MT profiles (mean ___ 
SEM =  11.0  _  1.1 per cross section, n  =  44 axons) exami- 
nation of both longitudinal  and cross sections from hun- 
dreds of vinblastine-treated axons failed to reveal a single 
unambiguous MT profile (Fig. 4, A  and B), except for a 
single MT in a single axon hillock. Quantitative morphom- 
etry  of a  large  number  of cross-sections  confirmed  the 
modest  decrease  in  diameter  of vinblastine-treated  cells 
(Fig. 4, C and D) that had been observed at the light mi- 
croscope level, and demonstrated that despite the elimina- 
tion  of MTs,  the  vinblastine-treated  axons  retained  the 
same number of neurofilaments as control cells (Fig. 4, E 
and F). Nonetheless, to ensure that the observations of mi- 
tochondrial  behavior described  below were  made  in  re- 
gions  completely devoid  of MTs,  all  observations  were 
made after/>75 min of drug treatment and were made far 
from the cell body and in regions where axons were of uni- 
form diameter. 
Mitochondria  exhibited movement in both the antero- 
grade and retrograde  directions  in control,  cytochalasin- 
treated, and vinblastine-treated cultures, but with dramati- 
cally  different  patterns  of  motility  (Figs.  6  and  7).  As 
previously shown  (Morris  and  Hollenbeck,  1993),  mito- 
chondria in control cells spent the majority of their time 
stationary  with  some  mitochondria  exhibiting  bidirec- 
tional  transport,  often  at velocities greater than  1  txm/s. 
Similarly, in the cytochalasin-treated cultures, many mito- 
chondria remained stationary while others moved bidirec- 
tionally at fast axonal transport rates of I txm/s or faster. In 
contrast,  while  mitochondria  in  vinblastine-treated  cells 
Morris and Hollenbeck Axonal Transport along Microtubules and f-Actin  1317 Figure 1.  Neurons grown in the absence of MTs or the absence of MFs. Phase contrast micrographs (Phase), immunofluorescent detec- 
tion of MTs, and R-phal detection of MFs in sympathetic neurons that were treated with drugs from the time of plating reveal the state 
of their cytoskeleton. (Top) Cells grown in the continuous presence of 20 Ixg/ml cytochalasin E for 3 d (Cyt) have a normal MT density, 
but lack a coherent MF array. (Bottom) Cells grown in the continuous presence of 100 nM vinblastine for 1 d (Vin) lack MTs but have an 
essentially  normal MF density.  The latter result was also obtained by growth in the continuous presence of nocodazole for 1 d (not 
shown). Bar, 20 txm. 
also  clearly  moved  bidirectionally,  the  movements  were 
consistently slower than in control or cytochalasin-treated 
cultures. Finally, in cultures treated with both cytochalasin 
and  vinblastine  simultaneously,  causing  both  MFs  and 
MTs to be disrupted while NFs remained intact (Fig. 5), all 
axonal mitochondria remained completely stationary dur- 
ing the entire  observation period  (56 mitochondria/min). 
In these  cells, video-enhanced phase contrast microscopy 
revealed that some organelle movement continued within 
the  cell  body (data  not shown),  where  residual  MTs  re- 
mained  (Fig.  3).  To  further  analyze  these  differences  in 
transport velocities, mitochondrial movements were quan- 
tified in detail for each drug treatment. 
A  comparison of the distribution of velocities which oc- 
cur in control, cytochalasin-treated, and vinblastine-treated 
cells (Fig. 7) confirmed that in normal growing axons, mi- 
tochondria spent a  large fraction of their movement time 
at  velocities  <~0.3 ~m/s yet continued  to display  a  broad 
range of fast movements t>0.3 Ixm/s with nearly equal fre- 
quencies.  The velocities of mitochondria in cytochalasin- 
treated  axons were  substantially  different  from controls: 
they moved with similar frequencies over a broad range of 
velocities with 70% of their movement time spent at >10.3 
~m/s.  As a  result,  their  mean velocity in both  directions 
was nearly double that in control axons. In contrast, mov- 
ing mitochondria in vinblastine-treated  axons spent most 
The Journal of Cell Biology, Volume 131, 1995  1318 Figure 2.  Mitochondrial distribution in live neurons grown in the absence of MFs or MTs. Neurons were grown in drugs from the time 
of plating, and phase contrast  micrographs (Phase) and epifluorescent images of mitochondria stained with R123 in living neurons 
(R123) were compared to determine the distribution of mitochondria. (Top) In cells grown in the continuous presence of cytochalasin E 
for 3 d (Cyt), mitochondria have entered the neurite and become distributed along its length. (Middle) In cells grown in the continuous 
presence of nocodazole for 1 d (Noc), mitochondria have failed to enter the neurite and are restricted to the cell body. (Bottom) Cells 
grown in the absence of drugs (Ctrl) show the typical distribution of motile mitochondria. Bar, 20 ~zm. 
of their time (average 79%) at velocities <0.3 i~m/s (simi- 
lar to controls) but displayed very few faster movements. 
When mean velocities of mitochondrial movement were 
calculated  from  pooled  anterograde  and  pooled  retro- 
grade data for each drug treatment,  the mean velocity in 
control cells fell between the faster mean velocities in cy- 
tochalasin-treated cells and the slower mean velocities in 
vinblastine-treated cells (Table I). 
To ascertain why mitochondria were distributed through- 
out neurites grown continuously in cytochalasin yet absent 
from neurites grown continuously in vinblastine  (Fig.  2), 
anterograde and retrograde mitochondrial movements in 
cytochalasin-treated and vinblastine-treated cultures were 
used to calculate net transport rates for mitochondria in 
each drug condition (Table I). As found previously (Mor- 
ris and Hollenbeck, 1993), the bidirectional movements of 
mitochondria  in  control  growing  cells  produced  a  net 
transport rate for the entire population of 1.1  i~m/min  in 
the anterograde direction, and thus the mitochondria ad- 
vanced within the elongating control axons. After cytocha- 
lasin treatment,  even though mean mitochondrial veloci- 
ties in both directions increased, the net transport rate was 
slowed to one eighth of the control rate while remaining 
net  anterograde.  In contrast, treatment  with vinblastine, 
while reducing the mean velocities in both directions, shifted 
the  balance  between  anterograde  and  retrograde  move- 
ments so as to produce rapid net retrograde transport (Ta- 
ble  I).  This  retrograde  mitochondrial  flow  could,  over 
time, produce axons entirely drained of mitochondria (Fig. 
2), and did, within the duration of vinblastine-treatment of 
these established cultures, produce long regions of distal 
neurite devoid of mitochondria (data not shown). 
Analysis of mitochondrial motile duty cycles (percent of 
time  spent  moving or  stationary)  revealed  how the  net 
transport rates were being modulated (Table I). The popu- 
lation of mitochondria in control cells underwent net an- 
terograde movement because, although they spent most of 
their  time  stationary, more of their  movement time  was 
spent moving anterograde than retrograde. The net trans- 
port of mitochondria in cytochalasin-treated cells was re- 
duced from the  rate  in  control cells  by both a  small  in- 
crease in time spent stationary, and by a reduction of greater 
than one third in the anterograde duty cycle, from 11% of 
time  in  control cells  to 7%  in  cytochalasin-treated cells, 
while the retrograde duty cycle remained almost unchanged. 
It is  notable  that this is  similar  to the  way axonal mito- 
chondria shift their net transport from anterograde to ret- 
rograde when axonal growth is blocked by reducing their 
anterograde duty cycle without  altering  their  retrograde 
duty cycle (Morris and Hollenbeck, 1993). 
Yet this is markedly different from the way net transport 
direction was reversed to retrograde in vinblastine-treated 
cells.  There, mitochondrial net transport was reversed not 
only by a reduction in the anterograde duty cycle, but also 
Morris and Hollenbeck Axonal Transport along Microtubules and  f-Actin  1319 Figure 3.  MFs and MTs in established cultures after cytochalasin or vinblastine treatment. In neurons grown under normal conditions 
for 1 d and then incubated with or without drugs for 1 h prior to fixation, immunofluorescent  detection of MTs and R-phal detection of 
MFs reveals the state of the cytoskeleton. (Top) Cells fixed without drug treatment (Ctrl) have robust MT and MF arrays. (Second row) 
Cells treated with cytochalasin E (Cyt) retain dense MTs but lack MFs. (Third and fourth rows) Cells treated with vinblastine  (V  in) vary 
from retaining virtually no MTs to retaining MTs in the cell body and a short proximal segment of the neurite, while their MF arrays ap- 
pear essentially identical to controls. Bar, 20 ixm. 
by a threefold increase in the retrograde duty cycle, from 
7% of time in control cells to 22% of time after vinblastine 
treatment. This is the first circumstance we have found in 
which the 1"etrograde duty cycle was modulated to change 
the net rate or net direction of mitochondrial transport. In 
addition, mitochondria in vinblastine-treated cells spent a 
larger fraction of their time moving, totaling 29% of time 
observed,  compared  to  both  control  cells  (20%  of  ob- 
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Figure 4.  Ultrastructural confirmation of the elimination of MTs 
but lack of general cytoskeletal disruption in vinblastine-treated 
axons.  (A) Four typical axonal cross-sections from control cul- 
tures  show  abundant  round  microtubule  profiles  interspersed 
with dot-like neurofilament cross sections and membranous or- 
ganelles.  (B) Five typical axonal cross sections from vinblastine- 
treated cultures reveal the absence of MTs but the presence of 
numerous  neurofilament  profiles,  along  with  membranous  or- 
ganelles.  Quantitative morphometry (C-F) shows that while  the 
cross sectional area of vinblastine-treated axons (D) is less than 
that of control axons (C) (t[1].,-1 <  .005), the number of neurofil- 
aments per cross section is not significantly different (t[2].  n-1 >  0.2) 
between  control  axons  containing  MTs  (E)  and  vinblastine- 
treated  axons lacking MTs  (F).  The mean of each distribution 
-SEM is shown within each histogram. For (C) and (E), n  =  44 
axons; for (D) and (F), n =  33 axons. Bar: (A and B) 200 nm. 
served  time),  and  cytochalasin-treated  cells  (13%  of ob- 
served time). Thus, although instantaneous rates of motility 
were slower in vinblastine-treated  cells, overall mitochon- 
drial movement was much more persistent in its direction. 
A  final feature  distinguishing  mitochondrial  motility in 
control and vinblastine-treated  cultures was the length of 
mitochondrial  excursions  between  stops.  First,  the  mean 
excursion  length  decreased  significantly  in  vinblastine- 
treated vs. control cultures, from 1.3 _+_ 0.20 txm (n = 299) 
in controls to 0.37  -  0.03  ixm (n =  243) in vinblastine.  In 
addition,  the  maximum  excursion  length,  which  is  more 
likely to reflect  the length  of the  track for movement in 
highly saltatory organelles such as mitochondria, decreased 
by  an  even  greater  degree  under  vinblastine  treatment 
(Table 1). 
Discussion 
Mitochondria Move along Both MTs and F-Actin But 
Not along NFs in Neuronal Processes 
In this study, we have demonstrated that mitochondria can 
move bidirectionally  along both  MTs  and  MFs  in  verte- 
brate axons by manipulating the cytoskeletons of neuronal 
processes and monitoring mitochondrial movements within 
the  affected  neurites.  First,  we  used  well-characterized 
techniques to grow neurites either lacking MFs or lacking 
MTs.  Neurites  grown  in  the  continuous  presence  of cy- 
tochalasin (Marsh and Letourneau,  1984) were curled and 
devoid of MFs, yet they contained MTs (Fig. 1) and mito- 
chondria (Fig. 2) along their entire lengths. Individual mi- 
tochondria in these  neurites  moved bidirectionally  at ve- 
locities  up  to  2  txm/s.  In  contrast,  growing  neurites  on 
adhesive  substrata  in the continuous presence  of vinblas- 
tine or nocodazole produced straight,  thin neurites which 
contained  MFs  along  their  lengths  but  which  contained 
neither  MTs  (Lamoureux  et  al.,  1990;  Fig.  1)  nor  mito- 
chondria  (Fig.  2).  The  latter  result  suggested  that  MTs 
were  necessary  and  sufficient  for the  transport  of mito- 
chondria  in  axons.  Although  the  net  direction  of mito- 
chondrial  transport  can  be  affected  by neuronal  process 
growth (Morris and Hollenbeck,  1993), it seemed unlikely 
that  mitochondria were failing to enter  the  MT-deficient 
neurites because of the slowed axonal growth produced by 
vinblastine  or nocodazole, since cytochalasin also slowed 
growth,  but  did  not  prevent  anterograde  mitochondrial 
movements. It seemed more likely that mitochondrial mo- 
tility on MFs in neurites was either absent or intrinsically 
net retrograde. 
To test  this  hypothesis,  we used  a  second approach to 
perturbing  the  cytoskeleton:  depolymerizing the  MTs  or 
MFs  in  established  neuronal  cultures  in which the  axons 
already contained normal cytoskeletal elements and large 
numbers of mitochondria. Using culture conditions in which 
we could  depolymerize virtually  all  MFs  as  detected  by 
R-phal  or  all  MTs  as  detected  by  immunofluorescence 
protocols (Osborn et al.,  1978; Fig. 3) and by electron mi- 
croscopy  (Fig.  4),  we  monitored  the  mitochondria  for 
movement on the remaining cytoskeletal filament system. 
We found that bidirectional  mitochondrial  transport con- 
tinued  in  both  cytochalasin-treated  cells  which  lacked  a 
coherent MF array but contained normal MT and NF ar- 
rays, and in vinblastine-treated cultures which lacked MTs 
but contained normal MF and NF arrays. Yet, when both 
MFs  and MTs were depolymerized by simultaneous  cyto- 
chalasin and vinblastine  treatments,  leaving only an intact 
Morris and Hollenbeck Axonal Transport along Microtubules and  f-Actin  1321 Figure 5.  NFs, MFs, and MTs in established cultures after simultaneous cytochalasin and vinblastine treatment. Cytoskeletal elements 
are revealed by double staining with antibody against NFs and R-phal detection of MFs (top cell) or double immunofluorescent detec- 
tion of NFs and MTs (bottom cell) in cultures grown under normal conditions for 1 d then incubated in vinblastine for 45 min followed 
by vinblastine plus cytochalasin for another 45 min prior to fixation and staining. In these cultures both MTs and MFs are depolymer- 
ized, while NF arrays remain extensive and essentially indistinguishable from controls (not shown). Bar, 20 ~zm. 
NF  skeleton,  mitochondrial  transport  ceased  completely. 
Thus, either MTs or MFs are sufficient for transport of mi- 
tochondria in embryonic chick sympathetic axons. In con- 
trast, because the discontinuity of NFs in neurites grown in 
cytochalasin  did  not  preclude  mitochondrial  transport 
there  (Fig.  2),  and  because the presence of NFs in com- 
bined  cytochalasin-  and  vinblastine-treated  cultures  did 
not  support  mitochondrial  movements,  NFs  are  neither 
necessary nor sufficient to support axonal transport of mi- 
tochondria. These  results  demonstrate  that  axonal trans- 
port of organelles can occur along actin filaments in intact 
vertebrate cells,  consistent with results  obtained in vitro 
(Kuznetsov et al., 1992; Langford et al., 1994; Kuznetsov et 
al.,  1994).  Indeed, Kuznetsov et  al.  (1992)  described  or- 
ganelles that appeared to be mitochondria that were seen 
to move along both MTs and MFs in vitro. 
Mitochondria Display Dramatically Different Patterns 
of Behavior on MTs and MFs 
Detailed quantification showed that mitochondrial behav- 
iors on the two cytoskeletal tracks were strikingly different 
in four ways (Fig.  7, Table I). First, the mean velocities of 
mitochondrial movements on MTs alone were nearly three 
times greater than those on MFs alone (Table I), consis- 
tent with the in vitro observations of Kuznetsov and co- 
workers (1992). Second, although mitochondria had slower 
mean velocities on MFs than on MTs, differences in motile 
duty cycle produced an 11-fold higher net transport rate 
on MFs than on MTs (Table I). On MFs, mitochondria tri- 
pled their retrograde duty cycle and reduced their antero- 
grade duty cycle relative  to control cells,  while  on MTs, 
they only reduced their anterograde duty cycle. As a  re- 
suit, mitochondria spent more than twice as much of their 
time moving when on MFs alone as when on MTs alone. 
Third, mitochondrial net transport on MFs alone was ret- 
rograde (reversed from the anterograde net transport ex- 
hibited on MTs alone or in control cells) (Morris and Hol- 
lenbeck,  1993; Table I). Fourth, the maximum excursion 
lengths of mitochondria in control cells were much greater 
than  those  on MFs  alone  (Table  I),  consistent  with  the 
demonstrated  lengths  of axonal  MTs  (Bray  and  Bunge, 
1981) and MFs (Bearer, E. L., and T. S. Reese. 1994. Mol. 
Biol. Cell 5:415a.). 
The efficient net retrograde transport of mitochondria 
along MFs  seems  likely to explain  their  failure  to  enter 
neurites which contain only MFs (Fig. 2).  The data from 
established,  vinblastine-,  or  nocodazole-treated  neurons 
indicate that the mitochondria are in fact capable of antero- 
grade movement on MFs, but because they spend the vast 
majority of their  time  moving retrogradely, they do not 
achieve anterograde translocation into the MF-containing 
neurites. This observation of retrograde mitochondrial net 
transport on axonal MFs has interesting implications for 
the  molecular  components underlying MF-based  axonal 
transport. First, if MFs in axons have, like MTs, a uniform 
polarity  orientation,  then  the  presence  of pointed-end- 
directed  MF-dependent  motor proteins  would be  neces- 
sary to produce the bidirectional movements seen in MT- 
deficient neurites  (Fig.  6, Table I). But since no pointed 
end-directed MF-dependent motor proteins have yet been 
identified in any system (Cheney et al.,  1993b),  we favor 
The Journal of Cell Biology, Volume 131,  1995  1322 Figure 6.  Examples of bidirectional mitochondrial movements in established cultures after cytoskeletal disruptions. With the growth 
cones out of view to the right, these series of typical low-light level video images show R123-1abeled fluorescent mitochondria moving in 
axons of 1-d-old cultures treated with cytochalasin E  for 1 h (left)  to disrupt MFs, or with vinblastine for 2 h  15 min (right)  to disrupt 
MTs. Images in each series show the same 25-p~m segment of axon at 3 s intervals (as indicated in the lower right of each panel); the top 
panel in each is a phase contrast image of the axon taken just before the epifluorescent sequence. In vinblastine-treated  cultures (Vin- 
blastine), one mitochondrion (open arrowhead)  moves anterograde (0-3 s), is stationary (3-9 s), moves retrograde (9-15 s), and then back 
anterograde (15-18 s); while another mitochondrion (closed  arrowhead) is briefly stationary (0-3 s) before moving rapidly retrograde 
(3-18 s); and two other mitochondria (right) move steadily and slowly retrograde. In cytochalasin-treated  cultures (Cytochalasin),  one 
mitochondrion (bracket) moves rapidly retrograde  (0-9 s), slowly retrograde (9-12 s), briefly anterograde (12-15 s), then retrograde 
(15-18 s); while another mitochondrion (arrowhead) enters the field at 6 s and moves rapidly anterograde. 
Morris and Hollenbeck  Axonal Transport  along  Microtubules  and  f-Actin  1323 Figure  7.  Relative frequency  of occurrence  of different  mito- 
chondrial velocities in established cultures. Velocities were deter- 
mined from the distance and duration of individual mitochondrial 
movements. Relative frequencies of movement at each velocity 
were calculated by pooling all velocity values for each direction 
in each drug condition, summing the time spent moving at each 
velocity in  one  direction and  dividing by the  total time  spent 
moving at any velocity in that direction. Anterograde velocities 
are designated as positive (cross-hatched  bars) and retrograde ve- 
locities as negative (white bars). Data are derived from analysis of 
72 mitochondria from 3 cells observed for 5,419 s in control cells, 
16 mitochondria from 5 cells observed for 1,248 s in cytochalasin- 
treated cells, and 16 mitochondria from 6 cells observed for 1,604 s 
in vinblastine-treated cells. 
the possibility that the 3:1 retrograde to anterograde duty 
cycle of mitochondria on MFs reflects a mixed orientation 
of MFs in axons such that the majority of plus- or barbed- 
ends of actin filaments are oriented toward the cell body 
with minus- or pointed-ends oriented outward toward the 
growth cone. It is possible that there may be subdomains 
of the  axonal MFs which have  uniform  polarity, such  as 
the  cortical  actin  underlying  the  axolemma,  while  more 
centrally-located actin may have mixed polarity. Although 
it seems unlikely, we cannot rule out the possibility that ax- 
ons in which the MT array is eliminated may develop differ- 
ent arrangements of MFs than control cells, rendering MF- 
based  transport  different  there  than  in  normal  axons. 
However,  the  retention of normal neurofilament densities 
in vinblastine-treated axons (Fig. 4) argues against a  gross 
Table L Motile Behavior of Mitochondria in Drug-treated 
Established Axons 
Maximum  excursion 
Duty cycle Mean velocity  Net velocity  length 
%  p.m/s  lean/rain  izm 
Control 
Anterograde  12  0.32  1.13  25 
Retrograde  7  0.38  --  15 
Stationary  81  --  --  -- 
Cytochalasin-treated 
Anterograde  7  0.62  0.14  6.7 
Retrograde  6  0.54  --  42 
Stationary  87  --  --  -- 
Vinblastine-treated 
Anterograde  7  0.23  --  1.1 
Retrograde  22  0.18  1.52  5.3 
Stationary  71  --  --  -- 
Velocities in the anterograde direction are designated as positive and in the retrograde 
direction as negative. Individual mitochondrial movements  were quantified and pooled 
for all cells  in each drug condition,  and duty cycle (percent  of time) was calculated 
from these pooled data. Individual distances moved in the anterograde  direction were 
summed within these pools and divided by total time mitochondria  spent moving an- 
terograde to determine mean velocity in the anterograde direction, and the same calcu- 
lations were performed for retrograde movements. Net velocity was determined by sum- 
ming single measurements of every mitochondrion's  net displacement  over an entire 
observation  period and dividing this by the duration of those single observation  peri- 
ods. Duty cycles were calculated  from the same data used to generate velocity distri- 
bution histograms in Fig. 5. Data for net velocity were derived from analysis of 63 mi- 
tochondria  from 3 cells observed for 4,434 s in control cells,  16 mitochondria  from 5 
cells observed for 1,401 s in cytochalasin-treated cells, and 16 mitochondria from 6 cells 
observed for 1,597 s in vinblastine-treated cells. Maximum excursion lengths were de- 
rived from analysis of 299 individual excursions  for control cells,  146 for cytochala- 
sin-treated cells, and 343 for vinblastine-treated  cells. 
reorganization of the cytoskeleton under MT-depolymer- 
izing conditions. 
Roles of Actin-based Movement in Axonal Transport 
One interpretation of these data would be to imagine ax- 
onal organelle transport as a  weighted mean  of the  MT- 
and MF-based behaviors shown in Fig. 7, with MF-based 
transport serving as a  separate carrier for organelles and 
contributing significantly in  its own  right  to  the  bidirec- 
tional flow of material within the axon. Yet in myriad stud- 
ies, MT-based transport alone has been demonstrated both 
in vitro and in vivo to be an effective system for the trans- 
port of membrane-bound organelles within axons. In addi- 
tion, due to the predominantly retrograde movements  of 
mitochondria on MFs, it seems unlikely that this form of 
transport contributes significantly to net anterograde move- 
ment. Indeed, the question arises of why another transport 
system should be required  at  all in  neurons.  We think  it 
likely that movements along MFs provide a localized trans- 
port system within axons to either cluster and localize or- 
ganelles in one  region or to move organelles which have 
become dissociated from MTs back onto MTs for contin- 
ued transport over long distances in either direction. This 
would  improve  the  efficiency of  axonal  transport  in  re- 
gions of the cell where MTs are few or absent (such as ax- 
onal branch points and growth cones) or could return or- 
ganelles  back  to  MTs  after  having  become  dissociated 
along a  MT's length or at the end of an MT.  Since single 
MTs  do not extend for the  entire length of longer axons 
(Bray  and  Bunge,  1981),  and  since  the  capacity  of  or- 
ganelles to  diffuse  within  cytoplasm is extremely limited 
The Journal of Cell Biology, Volume 131,  1995  1324 (Hou et al., 1990; Provance et al., 1993), providing a local 
mechanism  for  organelle  motility  could significantly  im- 
prove  the  efficiency  of transport  by  reducing  the  dwell 
times of organelles in these transport "dead zones". 
Taken together,  this body of data suggests  that within 
vertebrate  axons in vivo, mitochondria in particular, and 
perhaps organelles in general, utilize MT- and MF-depen- 
dent motor proteins  to move  along both MTs  and MFs. 
Consistent with this, immunoblotting of 100-fold purified 
mitochondrial  fractions  from  brain  revealed  reactivity 
with both  MT-  and MF-based  motor  proteins  (data  not 
shown).  Furthermore,  the intrinsic and  unique transport 
properties of the two cytoskeletal filament systems may be 
balanced  to  produce  a  coordinated  net  transport  of or- 
ganelles which meets the cell's regional and physiological 
needs. It should be possible, by manipulating the intracel- 
lular signalling pathways within neurons with modified cy- 
toskeletons, to elucidate the mechanisms by which MT- and 
MF-based  organelle  transport  are  regulated  and coordi- 
nately used within the cell. 
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